In this Issue:
Adalimumab/etanercept: antidrug antibodies and drug levels
Secukinumab for plaque psoriasis: a meta-analysis
Biologic drug survival in psoriasis
Anti-TNF-α mucosal healing in paediatric CD
Mucosal proteolytic cleavage of anti-TNF agents
Efficacy and safety of certolizumab pegol for CD
Biologics and immunomodulators: cancer risk in IBD
Biologics in RA: risk of hospitalised infections
Please login below to download this issue (PDF)